Low-Dose Doxycycline Effective for Lymphocytic Scarring Alopecias

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on March 21, 2025.

By Lori Solomon HealthDay Reporter

FRIDAY, March 21, 2025 – Relative to high-dose doxycycline, low-dose doxycycline is comparably effective but more tolerable for lymphocytic scarring alopecias, according to a research letter published online March 18 in the Journal of the American Academy of Dermatology.

Carli Needle, from the New York University Grossman School of Medicine in New York City, and colleagues evaluated the efficacy and tolerability of low- (20 mg twice daily [BID], 40 mg daily, and 50 mg daily) versus high-dose (50 mg BID, 100 mg daily, and 100 mg BID) doxycycline for lymphocytic scarring alopecias in a retrospective review. The analysis included 241 adults treated between 2009 and 2023.

The researchers found that high-dose doxycycline was associated with significantly higher rates of adverse effects (AEs), most commonly gastrointestinal symptoms and photosensitivity/rash. One in five (20.4 percent) of high-dose patients and 9.1 percent of low-dose patients reduced/discontinued doxycycline due to AEs. Doxycycline use was associated with improvement in inflammation severity, regardless of dose, when adjusting for the presence of at least one adjunctive anti-inflammatory medication. There was no significant difference seen between the groups for progression of hair loss or improvement in number of scalp symptoms. For patient-reported outcomes, there were no significant differences between dose groups after controlling for adjunctive therapies.

"This study highlights the benefits of low-dose doxycycline for lymphocytic scarring alopecias, showing comparable efficacy and improved tolerability relative to high doses," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-03-22 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords